Income statement
USD
| Metric | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|
| Revenue | 29M | 29M | 39M | 32M | 45M |
| Gross Profit | 10M | 14M | 21M | 14M | 11M |
| Operating Income | -10M | -751K | 3M | -6M | -13M |
| EBITDA | -6M | 4M | 6M | -2M | -8M |
| Net Income | -10M | -714K | 2M | -6M | -12M |
| EPS (Diluted) | β | β | β | β | β |
Consumer Cyclical
Live Price
Offline$0.0001
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 β Jun 12, 2026
Coverage: 245 bars Β· Jun 23, 2025 β Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Premier Exhibitions, Inc. (PRXIQ) is a Consumer Cyclical stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 β Jun 12, 2026). Baseline metrics include revenue growth of +0.1%, EPS growth of -1320.0%, a dividend yield of 0.0%. What stands out right now is revenue +0.1%, EPS -1320.0%, free cash flow -104.8% with operating margin -35.7% and ROIC -36.4%. Valuation is more restrained than many high-expectation growth names at price/sales 0.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines PRXIQ price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Cyclical peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PRXIQ
β
Normalized return
SPY
β
S&P 500
Excess Return
β
Relative to SPY
PRXIQ Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
β
Trailing 1Y
Uses the longest available daily history for PRXIQ and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$44.8M
+41.1% YoY
FY Net Income
-$12.5M
-115.7% YoY
Free Cash Flow
-$5.2M
-160.8% YoY
Revenue Growth
+0.1%
EPS Growth
-1320.0%
Gross Margin
32.7%
Net Margin
-35.6%
Income statement
USD
| Metric | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|
| Revenue | 29M | 29M | 39M | 32M | 45M |
| Gross Profit | 10M | 14M | 21M | 14M | 11M |
| Operating Income | -10M | -751K | 3M | -6M | -13M |
| EBITDA | -6M | 4M | 6M | -2M | -8M |
| Net Income | -10M | -714K | 2M | -6M | -12M |
| EPS (Diluted) | β | β | β | β | β |
Balance sheet
USD
| Metric | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|
| Cash & Equivalents | 5M | 3M | 6M | 2M | 4M |
| Total Assets | 37M | 30M | 38M | 26M | 32M |
| Total Liabilities | 27M | 10M | 16M | 10M | 12M |
| Shareholder Equity | 8M | 18M | 18M | 15M | 20M |
| Total Debt | 9M | 3M | 10M | 1M | 0 |
| Net Debt | 4M | -598K | 3M | -1M | -4M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
3M
-210.1% YoY
Capital Expenditures
3M
-126.6% YoY
Free Cash Flow
5M
-160.8% YoY
Key ratios
Gross Margin
32.7%
Operating Margin
-35.7%
Net Margin
-35.6%
ROE
-81.0%
Debt / Equity
1.16x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.